Projects of the Rittig Group
Sie befinden sich hier:
Currently, the Rittig Group focuses on the following research projects:
- Influence of tyrosine kinase inhibitors on human dendritic cells
- Augmenting DC function for rational immunotherapies in multiple myeloma